Heptares Therapeutics Ltd, a drug discovery company targeting G-protein-coupled receptors, announced that it has successfully generated a stabilised receptor (StaR) to a GPCR target nominated by Novartis using its proprietary StaR technology.
ACT Biotech, Inc. released data on additional analysis of the Phase 2 clinical trial of telatinib in patients with metastatic stomach cancer that further supports the highly-potent nature of the antiangiogenic agent.
QRxPharma Limited has initiated a Phase 3 trial (Study 022) to compare the tolerability and safety profile of MoxDuo IR to equi-analgesic doses of either morphine or oxycodone given alone.
Mylan Inc. said it settled a lawsuit with Pfizer Inc. over the blockbuster cholesterol drug Lipitor, but terms of the settlement are confidential. The settlement deal is subject to review by the Justice Department and Federal Trade Commission.
Abbott Laboratories will report its fourth-quarter and full-year results on Wednesday before the market opens. Wall Street analysts will be watching for Abbott's 2011 earnings guidance, with particular focus on sales of the company's best-selling product Humira.
Mylan Inc. said it is now shipping a generic version of Pfizer Inc.'s heartburn drug Protonix. One of the key patents supporting Protonix expired Wednesday, and Mylan said it received final approval from the Food and Drug Administration.
Federal health officials announced new security measures to combat Medicare fraud, including tougher screenings for providers and the ability to withhold payments during investigations.
Eli Lilly and Company announced that John H. Johnson, senior vice president and president of Lilly Oncology, has resigned effective January 28, 2011. A successor will be announced in the coming weeks.
Health care giant Johnson & Johnson, hammered by numerous recalls that have kept some popular nonprescription medicines and other products off the market, posted a 12 percent profit decline and a 5.5 percent drop in revenue for the fourth quarter.
Hamilton Robotics has integrated Peak Robotics' KiNEDx robot series with Hamilton's MICROLAB STAR automated liquid handling workstation. The KiNEDx 4- and 5-axis robots increase the STAR's access to microplate samples and third-party devices.
Genetix announced the launch of its ClonePix 2 system – the second generation system based on the company’s well-established and successful technology and chemistries for clone screening and selection.
Despite what you might have heard, genetic sequencing alone is not enough to understand human disease. Researchers have shown that functional tests are absolutely necessary to understand the biological relevance of the results of sequencing studies.
HIV adapts in a surprising way to survive and thrive in its hiding spot within the human immune system, scientists have learned. While the finding helps explain why HIV remains, it also offers researchers a new, unexpected way to try to stop the virus.
PerkinElmer, Inc. announced the launch of a next generation DNA sequencing and data analysis services for genome sequencing at the company's lab in Branford, Conn.
Drug developer Teva Pharmaceutical Industries Ltd. said it signed a new three-year, $1.5 billion credit facility. The company said the new facility is part of its strategy to secure liquidity for future business needs through revolving credit lines.